Skip to main content
Equibles
AXGN logo

AXGN · Axogen, Inc. · Metrics

Track AXGN — free

Use AXGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AXGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$38.06 +1.38 (+3.76%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$2.05B
Shares
53.76M
Volume · Oct 23 2.19M Avg daily vol (3M) 1.23M

AXGN metrics

84 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$38.06
Market cap
$2.05B

Price action

20 metrics
Price change (1W)
+9.9%
Price change (30D)
-12.3%
Price change (3M)
-3.6%
Price change (6M)
-3.0%
Price change (YTD)
+16.3%
Price change (1Y)
+110.9%
Trailing year
Price change (5Y)
+167.8%
52-week high
$51.73
52-week low
$17.77
Change from 52-week high
-26.4%
Change from 52-week low
+114.2%
Annualized volatility
55.2%
Annualized volatility (3M)
50.5%
Beta
0.9
RSI (14D)
46.4
Price vs SMA 50
-12.0%
Price vs SMA 200
-3.0%
Avg volume (3M)
1.23M
Relative volume
1.8
Average dollar volume
$52.24M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
53.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
8.2×
reciprocal yield 12.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
8.1×
reciprocal yield 12.3%
P / book
8.0
reciprocal yield 12.5%
FCF yield
0.4%
TTM · current market cap
Buyback yield
—
P / FCF
238.0
reciprocal yield 0.4%
P / operating cash flow
136.0
reciprocal yield 0.7%
Earnings yield
-1.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.3×
reciprocal yield 23.3%
EV / revenue historical average (5Y)
4.0×
reciprocal yield 25.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
74.6%
Operating margin
-5.1%
Trailing 12 months
Net margin
-13.4%
Gross profit (TTM)
$187.26M
Operating profit (TTM)
−$12.85M
Net income (TTM)
−$33.55M
Trailing 12 months
Diluted EPS (TTM)
$-0.68
FCF margin
3.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.73

Growth

11 metrics
Revenue growth YoY
+23.1%
Year over year
Net income growth YoY
-361.8%
Revenue (TTM)
$251.17M
Trailing 12 months
EPS growth YoY
-400.0%
Shares change YoY
+11.2%
Year over year · more shares
Revenue CAGR (3Y)
+17.6%
Revenue CAGR (5Y)
+14.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-13.1%
Return on assets
-11.0%
Debt / equity
0.4
Current ratio
6.6
EBITDA (TTM)
−$6.36M
Free cash flow (TTM)
$8.60M
Quick ratio
5.0
Interest coverage
-3.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$6.86M
Latest balance sheet
Cash & equivalents
$94.57M
Total assets
$304.86M
Total debt
$48.39M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$15.05M
Capital expenditures (TTM)
$6.45M
R&D (TTM)
$36.05M
SG&A (TTM)
—
Stock compensation (TTM)
$37.64M
R&D / revenue
14.4%
Stock compensation / revenue
15.0%

Ownership (13F)

9 metrics
13F filers
254
13F filer change QoQ
+31
Institutional ownership
98.0%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
42.8%
Private-fund adviser ownership
39.8%
Active holders' share change QoQ
+2.9%
Holder tenure
12.0
Price vs estimated holder cost
+67.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.9%

Short interest

3 metrics
Short interest
8.7%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
79 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.66M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 805928 CUSIP 05463X106 13F (30d) 27 filings 27 filers Visit website Investor relations